Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.Jinxin Fertility Group Limited 锦欣生殖医疗集团有限公司* (Incorporated under the laws of the Cayman Islands with limited liability) (Stock Code: 1951) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 25 2024 Reference is made to the circular of Jinxin Fertility Group Limited (the “Company”) dated May 31 2024 (the “Circular”) incorporating amongst others the notice (the “Notice”) of annual general meeting of the Company (the “Annual General Meeting”). Unless the context otherwise requires capitalised terms used herein shall have the same meanings as those defined in the Circular.At the Annual General Meeting held on June 25 2024 all the proposed resolutions as set out in the Notice were taken by poll.All Directors attended the Annual General Meeting either in person or by electronic means.The Company’s Hong Kong share registrar Computershare Hong Kong Investor Services Limited was appointed as the scrutineer at the Annual General Meeting for the purpose of vote-taking. The poll results in respect of the respective resolutions proposed at the Annual General Meeting were as follows: Number of votes cast and approximate percentage of ORDINARY RESOLUTIONS total number of votes cast For Against 1. To receive and adopt the audited consolidated financial statements of 381127975 81640 the Company for the year ended December 31 2023 and the reports of 99.978584% 0.021416% the directors and auditor thereon.– 1 –Number of votes cast and approximate percentage of ORDINARY RESOLUTIONS total number of votes cast For Against 2. (i) To re-elect Mr. Zhong Yong as an executive director. 366367597 14842018 96.106599%3.893401% (ii) To re-elect Ms. Hu Zhe as a non-executive director. 363125996 18083619 95.256253%4.743747% (iii) To re-elect Mr. Li Jianwei as an independent non-executive 371213970 9995645 director. 97.377914% 2.622086% (iv) To re-elect Mr. Ye Changqing as an independent non-executive 318107977 63101638 director. 83.446997% 16.553003% 3. To authorise the board of directors of the Company (the “Board”) to 380480735 728880 fix the remuneration of the directors of the Company (the “Directors”). 99.808798% 0.191202% 4. To declare a final dividend of HK$5.95 cents per share for the year 381208615 1000 ended December 31 2023. 99.999738% 0.000262% 5. To re-appoint Deloitte Touche Tohmatsu as auditor of the Company to 379797342 1412273 hold office until the conclusion of the next annual general meeting of 99.629528% 0.370472% the Company and to authorise the Board to fix their remuneration for the year ending December 31 2024. 6. To approve and adopt the amendments to the 2022 Share Award 325264230 55945385 Scheme (as defined in the notice convening the Annual General 85.324246% 14.675754% Meeting). 7. To approve and adopt the Scheme Mandate Limit (as defined in the 325108176 56101439 notice convening the Annual General Meeting). 85.283310% 14.716690% 8. To approve and adopt the Service Provider Sublimit (as defined in the 325108176 56101439 notice convening the Annual General Meeting). 85.283310% 14.716690% 9(A). To grant a general mandate to the Directors to offer allot issue and 314678444 66531171 deal with additional shares in the Company (including any sale or 82.547352% 17.452648% transfer of treasury shares of the Company) not exceeding 20% of the total number of issued shares of the Company (excluding any treasury shares of the Company).– 2 –Number of votes cast and approximate percentage of ORDINARY RESOLUTIONS total number of votes cast For Against 9(B). To grant a general mandate to the Directors to repurchase shares in the 381208615 1000 Company not exceeding 10% of the total number of issued shares of 99.999738% 0.000262% the Company (excluding any treasury shares of the Company). 9(C). To extend the general mandate granted to the Directors to allot issue 314915535 66294080 and deal with shares by the number of shares repurchased by the 82.609547% 17.390453% Company.Number of votes cast and approximate percentage of SPECIAL RESOLUTION total number of votes cast For Against 10. To consider and approve the proposed amendments to the Articles of 381208615 1000 Association and to adopt the fifth amended and restated Articles of 99.999738% 0.000262% Association.Notes: (1) As at the date of the Annual General Meeting (i) the total number of Shares in issue was 2757706043 Shares and (ii) there were no treasury Shares held by the Company. (2) There was no Share entitling the Shareholders to attend and vote only against the proposed resolutions at the Annual General Meeting. No party has stated its intention in the Circular that it would vote against any proposed resolution or that it would abstain from voting at the Annual General Meeting. (3) As at the date of the Annual General Meeting the trustees of the Pre-IPO RSU Scheme and the 2022 Share Award Scheme (the “Trustees”) held in aggregate 88028794 Shares being unvested Restricted Shares granted thereunder.Save for the Trustees who were required under Rule 17.05A of the Listing Rules to abstain from voting on matters that require Shareholders’ approval under the Listing Rules no other Shareholder was required to abstain from voting in respect of any resolution at the Annual General Meeting.Accordingly the total number of Shares entitling the holders thereof to attend and vote for or against the resolutions proposed at the Annual General Meeting was 2669677249 Shares. (4) Please refer to the Notice for the full text of the resolutions. – 3 –As more than 50% of votes were cast in favour of each of the ordinary resolutions numbered 1 to 9 all of the above ordinary resolutions were duly passed at the Annual General Meeting. As more than 75% of votes were cast in favour of the special resolution numbered 10 such resolution was duly passed at the Annual General Meeting. By order of the Board Jinxin Fertility Group Limited Zhong Yong Chairman Hong Kong June 25 2024 As at the date of this announcement the Board of Directors of the Company comprises Mr. Zhong Yong Dr. John G. Wilcox Mr. Dong Yang Ms. Lyu Rong and Dr. Geng Lihong as executive Directors; Mr. Fang Min Ms. Hu Zhe and Ms. Yan Xiaoqing as non-executive Directors; and Dr. Chong Yat Keung Mr. Li Jianwei Mr. Wang Xiaobo and Mr. Ye Changqing as independent non-executive Directors.* For identification purpose only –4–